Lucid Diagnostics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LUCD and other ETFs, options, and stocks.About LUCD
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma.
CEOLishan Aklog
CEOLishan Aklog
Employees72
Employees72
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2018
Founded2018
Employees72
Employees72
LUCD Key Statistics
Market cap158.63M
Market cap158.63M
Price-Earnings ratio-1.35
Price-Earnings ratio-1.35
Dividend yield—
Dividend yield—
Average volume513.57K
Average volume513.57K
High today$1.25
High today$1.25
Low today$1.20
Low today$1.20
Open price$1.25
Open price$1.25
Volume508.29K
Volume508.29K
52 Week high$1.80
52 Week high$1.80
52 Week low$0.8107
52 Week low$0.8107
Stock Snapshot
Lucid Diagnostics(LUCD) stock is priced at $1.20, giving the company a market capitalization of 158.63M. It carries a P/E multiple of -1.35.
During the trading session on 2026-01-19, Lucid Diagnostics(LUCD) shares reached a daily high of $1.25 and a low of $1.20. At a current price of $1.20, the stock is 0.0% higher than the low and still -4.0% under the high.
Trading volume for Lucid Diagnostics(LUCD) stock has reached 508.29K, versus its average volume of 513.57K.
The stock's 52-week range extends from a low of $0.81 to a high of $1.80.
The stock's 52-week range extends from a low of $0.81 to a high of $1.80.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own LUCD. This list is generated using Robinhood data, and it’s not a recommendation.